Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 677,522 | 2,699,400 | 1,981,952 | 1,323,873 | 649,993 |
| Accounts payable and accrued liabilities | -552,990 | -2,408,000 | -1,800,487 | -1,193,916 | -615,630 |
| Other Working Capital | 88,767 | 108,700 | 19,628 | 43,362 | 19,733 |
| Other Operating Activity | -115,180 | -205,700 | -86,303 | -69,556 | -3,602 |
| Operating Cash Flow | $98,119 | $194,400 | $114,790 | $103,763 | $50,494 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -34,748 | -994,200 | -971,782 | -1,011,678 | -883,063 |
| PPE Investments | -35,725 | -112,600 | -77,873 | -50,304 | -33,078 |
| Net Acquisitions | N/A | -99,300 | -99,386 | 1,360 | N/A |
| Purchase Sale Intangibles | N/A | -1,500 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -1,500 | 0 | 0 | 0 |
| Investing Cash Flow | $-70,473 | $-1,207,600 | $-1,149,041 | $-1,060,622 | $-916,141 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,186,200 | 1,186,220 | 1,186,220 | 1,186,220 |
| Debt Repayment | -115 | -500 | -367 | -254 | -104 |
| Common Stock Issued | 4,424 | 17,600 | 13,218 | 8,444 | 4,177 |
| Common Stock Repurchased | N/A | -215,700 | -125,000 | -125,000 | N/A |
| Other Financing Activity | 0 | -14,000 | -13,876 | -443 | 0 |
| Financing Cash Flow | $4,309 | $973,600 | $1,060,195 | $1,068,967 | $1,190,293 |
| Exchange Rate Effect | -1,996 | 3,000 | 21,167 | 13,666 | 6,877 |
| Beginning Cash Position | 434,544 | 471,100 | 471,133 | 471,133 | 471,133 |
| End Cash Position | 464,503 | 434,500 | 518,244 | 596,907 | 802,656 |
| Net Cash Flow | $29,959 | $-36,600 | $47,111 | $125,774 | $331,523 |
| Free Cash Flow | |||||
| Operating Cash Flow | 98,119 | 194,400 | 114,790 | 103,763 | 50,494 |
| Capital Expenditure | -35,725 | -112,800 | -77,987 | -50,412 | -33,078 |
| Free Cash Flow | 62,394 | 81,600 | 36,803 | 53,351 | 17,416 |